Cargando…
Incremental cost burden among patients with severe uncontrolled asthma in the United States
BACKGROUND: The economic burden of severe asthma and severe uncontrolled asthma (SUA) is significant. Updated assessments of health care resource utilization (HCRU) and cost are needed given the increase in treatment options and updates to guidelines in recent years. OBJECTIVE: To describe all-cause...
Autores principales: | Burnette, Autumn, Wang, Yan, Rane, Pallavi B, Chung, Yen, Princic, Nicole, Park, Julie, Llanos, Jean-Pierre, Lindsley, Andrew W, Ambrose, Christopher S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387979/ https://www.ncbi.nlm.nih.gov/pubmed/37404066 http://dx.doi.org/10.18553/jmcp.2023.29.7.825 |
Ejemplares similares
-
What Will Uncontrolled Asthma Cost in the United States?
por: Nurmagambetov, Tursynbek A., et al.
Publicado: (2019) -
The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019) -
Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review
por: Korn, Stephanie, et al.
Publicado: (2023) -
Racial and Ethnic Minorities at the Highest Risk of Uncontrolled Moderate-to-Severe Asthma: A United States Electronic Health Record Analysis
por: George, Maureen, et al.
Publicado: (2023) -
Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)